Irritable Bowel Syndrome: Epidemiology, Overlap Disorders, Pathophysiology and Treatment

Overview

Journal World J Gastroenterol

Publisher Baishideng Publishing Group

Specialty Gastroenterology

Date 2023 Jul 21

PMID 37475846

Authors

Kai-Yue Huang

Feng-Yun Wang

Mi Lv

Xiang-Xue Ma

Xu-Dong Tang

Lin Lv

Affiliations

Soon will be listed here.

Abstract

Irritable bowel syndrome (IBS) is a common chronic gastrointestinal disease with a significant impact on patients' quality of life and a high socioeconomic burden. And the understanding of IBS has changed since the release of the Rome IV diagnosis in 2016. With the upcoming Rome V revision, it is necessary to review the results of IBS research in recent years. In this review of IBS, we can highlight future concerns by reviewing the results of IBS research on epidemiology, overlap disorders, pathophysiology, and treatment over the past decade and summarizing the latest research.

Citing Articles

From Inflammasomes to Pyroptosis: Molecular Mechanisms in Chronic Intestinal Diseases - Opportunity or Challenge?.

Fang J, Zhu W, Yu D, Zhu L, Zha H, Tang J J Inflamm Res. 2025; 18:3349-3360.

PMID: 40070928 PMC: 11895680. DOI: 10.2147/JIR.S498703.

The diagnostic criteria for psychosomatic research-revised (DCPR-R) in a National China multicenter cohort of patients with irritable bowel syndrome and overlapping gastroesophageal reflux disease.

Li P, Tang Y, Liu L, Yang L, Yang L, Sun Z BMC Gastroenterol. 2025; 25(1):136.

PMID: 40045215 PMC: 11883918. DOI: 10.1186/s12876-025-03726-0.

Improving Irritable Bowel Syndrome (IBS) Symptoms and Quality of Life with Quebracho and Chestnut Tannin-Based Supplementation: A Single-Centre, Randomised, Double-Blind, Placebo-Controlled Clinical Trial.

Molino S, De Lellis L, Morone M, Cordara M, Larsen D, Piccinocchi R Nutrients. 2025; 17(3).

PMID: 39940411 PMC: 11820850. DOI: 10.3390/nu17030552.

Gut microbial dysbiosis associated to diarrheic irritable bowel syndrome can be efficiently simulated in the Mucosal ARtificial COLon (M-ARCOL).

Uriot O, Deschamps C, Scanzi J, Brun M, Kerckhove N, Duale C Bioengineered. 2025; 16(1):2458362.

PMID: 39902883 PMC: 11796540. DOI: 10.1080/21655979.2025.2458362.

Impact of Microbiota on Irritable Bowel Syndrome Pathogenesis and Management: A Narrative Review.

Almonajjed M, Wardeh M, Atlagh A, Ismaiel A, Popa S, Rusu F Medicina (Kaunas). 2025; 61(1).

PMID: 39859091 PMC: 11766696. DOI: 10.3390/medicina61010109.

References

Agreus L, Svardsudd K, Nyren O, Tibblin G . Irritable bowel syndrome and dyspepsia in the general population: overlap and lack of stability over time. Gastroenterology. 1995; 109(3):671-80. DOI: 10.1016/0016-5085(95)90373-9. View

Gwee K, Lu C, Ghoshal U . Epidemiology of irritable bowel syndrome in Asia: something old, something new, something borrowed. J Gastroenterol Hepatol. 2009; 24(10):1601-7. DOI: 10.1111/j.1440-1746.2009.05984.x. View

Whorwell P, Houghton L, Taylor E, Maxton D . Physiological effects of emotion: assessment via hypnosis. Lancet. 1992; 340(8811):69-72. DOI: 10.1016/0140-6736(92)90394-i. View

Vakil N, van Zanten S, Kahrilas P, Dent J, Jones R . The Montreal definition and classification of gastroesophageal reflux disease: a global evidence-based consensus. Am J Gastroenterol. 2006; 101(8):1900-20. DOI: 10.1111/j.1572-0241.2006.00630.x. View

Zheng L, Lai Y, Lu W, Li B, Fan H, Yan Z . Pinaverium Reduces Symptoms of Irritable Bowel Syndrome in a Multicenter, Randomized, Controlled Trial. Clin Gastroenterol Hepatol. 2015; 13(7):1285-1292.e1. DOI: 10.1016/j.cgh.2015.01.015. View

Sperber A, Bangdiwala S, Drossman D, Ghoshal U, Simren M, Tack J . Worldwide Prevalence and Burden of Functional Gastrointestinal Disorders, Results of Rome Foundation Global Study. Gastroenterology. 2020; 160(1):99-114.e3. DOI: 10.1053/j.gastro.2020.04.014. View

Holtmann G, Ford A, Talley N . Pathophysiology of irritable bowel syndrome. Lancet Gastroenterol Hepatol. 2017; 1(2):133-146. DOI: 10.1016/S2468-1253(16)30023-1. View

Black C, Ford A . Global burden of irritable bowel syndrome: trends, predictions and risk factors. Nat Rev Gastroenterol Hepatol. 2020; 17(8):473-486. DOI: 10.1038/s41575-020-0286-8. View

AlButaysh O, AlQuraini A, Almukhaitah A, Alahmdi Y, Alharbi F . Epidemiology of irritable bowel syndrome and its associated factors in Saudi undergraduate students. Saudi J Gastroenterol. 2020; 26(2):89-93. PMC: 7279070. DOI: 10.4103/sjg.SJG_459_19. View

10.

Dinan T, Cryan J . Gut-brain axis in 2016: Brain-gut-microbiota axis - mood, metabolism and behaviour. Nat Rev Gastroenterol Hepatol. 2017; 14(2):69-70. DOI: 10.1038/nrgastro.2016.200. View

11.

Dai C, Zheng C, Jiang M, Ma X, Jiang L . Probiotics and irritable bowel syndrome. World J Gastroenterol. 2013; 19(36):5973-80. PMC: 3785618. DOI: 10.3748/wjg.v19.i36.5973. View

12.

DeBenedittis G, Cigada M, Bianchi A, Signorini M, Cerutti S . Autonomic changes during hypnosis: a heart rate variability power spectrum analysis as a marker of sympatho-vagal balance. Int J Clin Exp Hypn. 1994; 42(2):140-52. DOI: 10.1080/00207149408409347. View

13.

Chey W, Hashash J, Manning L, Chang L . AGA Clinical Practice Update on the Role of Diet in Irritable Bowel Syndrome: Expert Review. Gastroenterology. 2022; 162(6):1737-1745.e5. DOI: 10.1053/j.gastro.2021.12.248. View

14.

Dinan T, Cryan J . Brain-Gut-Microbiota Axis and Mental Health. Psychosom Med. 2017; 79(8):920-926. DOI: 10.1097/PSY.0000000000000519. View

15.

Madsen A, Halkjaer S, Hojer Christensen A, Gunther S, Browne P, Kallemose T . The effect of faecal microbiota transplantation on abdominal pain, stool frequency, and stool form in patients with moderate-to-severe irritable bowel syndrome: results from a randomised, double-blind, placebo-controlled study. Scand J Gastroenterol. 2021; 56(7):761-769. DOI: 10.1080/00365521.2021.1915375. View

16.

You S, Ma Y, Yan B, Pei W, Wu Q, Ding C . The promotion mechanism of prebiotics for probiotics: A review. Front Nutr. 2022; 9:1000517. PMC: 9581195. DOI: 10.3389/fnut.2022.1000517. View

17.

Chen G, Xie X, Peng C . Treatment of Irritable Bowel Syndrome by Chinese Medicine: A Review. Chin J Integr Med. 2021; 29(4):377-384. DOI: 10.1007/s11655-021-3521-4. View

18.

El-Salhy M, Hatlebakk J, Hausken T . Possible role of peptide YY (PYY) in the pathophysiology of irritable bowel syndrome (IBS). Neuropeptides. 2019; 79:101973. DOI: 10.1016/j.npep.2019.101973. View

19.

Prior A, Colgan S, Whorwell P . Changes in rectal sensitivity after hypnotherapy in patients with irritable bowel syndrome. Gut. 1990; 31(8):896-8. PMC: 1378618. DOI: 10.1136/gut.31.8.896. View

20.

Wang Y, Chen N, Niu F, Li Y, Guo K, Shang X . Probiotics therapy for adults with diarrhea-predominant irritable bowel syndrome: a systematic review and meta-analysis of 10 RCTs. Int J Colorectal Dis. 2022; 37(11):2263-2276. DOI: 10.1007/s00384-022-04261-0. View